ELI LILLY & Co is 730.1x more valuable than Palvella Therapeutics, Inc. by market capitalization ($1.070 T vs $1.47 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PVLA | LLY |
|---|---|---|
| Market cap | $1.47 B | $1.070 T |
| US-listed rank | #2333 | #10 |
| Revenue (latest FY) | $42.81M | $65.18B |
| Net income (latest FY) | -$41.72M | $20.64B |
| Net margin | -97.4% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 774 | 989 |
ELI LILLY & Co is 730.1x more valuable than Palvella Therapeutics, Inc. by market capitalization ($1.070 T vs $1.47 B).
Full pages: Palvella Therapeutics, Inc. and ELI LILLY & Co, or browse the full rankings.